EUROGIN 2022 PRELIMINARY Program Topics

• HPV diseases and SARS-CoV-2: Impact and lessons from the pandemic
  • COVID-19 and HPV vaccination
  • COVID-19 and cervical cancer screening
• HPV related cancer control by age: current perspectives
  • Routine screening: how to modulate and manage HPV screening by age
  • HPV vaccination strategies, impact and safety by age, current knowledge
• Targeting high risk populations for control of HPV related cancer
• Screening in special situations: from evidence to practical guidance
• HPV screening: first experiences and assessment
• Assessing risk of cervical cancer in the post vaccination era
• Quality assurance of self-sampling for cervical screening and disease management
• New evidence of the effectiveness of HPV vaccination against invasive cervical cancer: a global view
• Cervical adenocarcinoma in situ: a review
• New developments in colposcopy practice
• Digital projects in HPV related disease
• New strategies for monitoring disease in the test of cure population
• Clinical applications of emerging sequencing technologies
• Innovative SARS-CoV-2 molecular diagnostic devices: opportunity for worldwide HPV screening
• Is HPV genotyping transforming primary HPV screening?
• Applying methylation assays for clinical use
• VALHUDES / VALGENT